<DOC>
	<DOCNO>NCT01033864</DOCNO>
	<brief_summary>This open-label , 2-arm study compare pharmacokinetics CellCept mycophenolate sodium kidney transplant patient calcineurininhibitor-free mycophenolic acid-based therapy . On study day patient take prescribed medication ( either CellCept mycophenolate sodium ) . Blood sample draw directly interval 12 hour intake study medication . Anticipated time study treatment 12 hour target sample size 24 .</brief_summary>
	<brief_title>A Pharmacokinetic Study CellCept ( Mycophenolate Mofetil ) Versus Mycophenolate Sodium Kidney Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>adult patient , &gt; /=18 year age kidney transplantation &gt; /=6 month ago mycophenolic acidbased , calcineurininhibitorfree therapy &gt; /=3 month , &gt; /=1 month stable dose cotherapy 5mg prednisone &gt; /=1 month active gastrointestinal ulcus severe diarrhea od gastrointestinal disease severe impairment renal function current malignancy LeschNyhan KelleySeegmillerSyndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>